MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features.

MLH1 promoter methylation frequency in colorectal cancer patients and related clinicopathological and molecular features.

To describe the frequency of MLH1 promoter methylation in colorectal cancer (CRC); to explore the associations between MLH1 promoter methylation and clinicopathological and molecular factors using a systematic review and meta-analysis.A literature search of the PubMed and Embase databases was conduc...

Full description

Bibliographic Details
Main Authors:	Xia Li, Xiaoping Yao, Yibaina Wang, Fulan Hu, Fan Wang, Liying Jiang, Yupeng Liu, Da Wang, Guizhi Sun, Yashuang Zhao
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2013-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3612054?pdf=render

Similar Items

CpG Island Methylator Phenotype and Prognosis of Colorectal Cancer in Northeast China
by: Xia Li, et al.
Published: (2014-01-01)

Can Vascular Endothelial Growth Factor and Microvessel Density Be Used as Prognostic Biomarkers for Colorectal Cancer? A Systematic Review and Meta-Analysis
by: Yibaina Wang, et al.
Published: (2014-01-01)

Novel DNA variants and mutation frequencies of hMLH1 and hMSH2 genes in colorectal cancer in the Northeast China population.
by: Fulan Hu, et al.
Published: (2013-01-01)

Prevalence of pathological germline mutations of hMLH1 and hMSH2 genes in colorectal cancer.
by: Dandan Li, et al.
Published: (2013-01-01)

Spreading of Alu methylation to the promoter of the MLH1 gene in gastrointestinal cancer.
by: Xiyin Wang, et al.
Published: (2011-01-01)

Metabolomic Markers of Colorectal Tumor With Different Clinicopathological Features
by: Zhiping Long, et al.
Published: (2020-06-01)

Diagnostic Application of hMLH1 Methylation in Hereditary Non-Polyposis Colorectal Cancer
by: Nagahide Matsubara
Published: (2004-01-01)

Development of a liquid biopsy based purely quantitative digital droplet PCR assay for detection of MLH1 promoter methylation in colorectal cancer patients
by: Danyi Wang, et al.
Published: (2021-07-01)

Inhibition of DNA Methylation at the MLH1 Promoter Region Using Pyrrole–Imidazole Polyamide
by: Ken-ichi Shinohara, et al.
Published: (2016-12-01)

Promoter Methylation of p16INK4A, hMLH1, and MGMT in Liquid-Based Cervical Cytology Samples Compared with Clinicopathological Findings and HPV Presence
by: Aris Spathis, et al.
Published: (2011-01-01)

Frequency of gene hMLH1 promoter methylation in the stomach antral and body area tissue of chronic atrophic pangastritis patients
by: Rita Kupčinskaitė-Noreikienė, et al.
Published: (2013-09-01)

The Role of MLH1 Constitutional Methylation in Lynch Syndrome
by: Diana Touceira Pinto
Published: (2019)

Association between MLH1 -93G>a polymorphism and risk of colorectal cancer.
by: Ting Wang, et al.
Published: (2012-01-01)

Correlation of <it>MLH1</it> and <it>MGMT</it> expression and promoter methylation with genomic instability in patients with thyroid carcinoma
by: Santos Juliana Carvalho, et al.
Published: (2013-02-01)

MLH1–93 G/a polymorphism is associated with MLH1 promoter methylation and protein loss in dysplastic sessile serrated adenomas with BRAFV600E mutation
by: Lochlan J. Fennell, et al.
Published: (2018-01-01)

Comprehensive profiling of DNA methylation in colorectal cancer reveals subgroups with distinct clinicopathological and molecular features
by: Vaithilingam Aparna, et al.
Published: (2010-05-01)

Role of MLH1 methylation in esophageal cancer carcinogenesis and its clinical significance
by: Li J, et al.
Published: (2018-02-01)

Clinicopathologic Features and Prognosis of BRAF Mutated Colorectal Cancer Patients
by: Wen-Long Guan, et al.
Published: (2020-11-01)

Clinicopathological features of colorectal polyps in 2002 and 2012
by: Yoon Jeong Nam, et al.
Published: (2019-01-01)

Comparison of the endocytoscopic and clinicopathologic features of colorectal neoplasms
by: Kenichi Takeda, et al.
Published: (2016-03-01)

The Correlation of MGMT Promoter Methylation and Clinicopathological Features in Gastric Cancer: A Systematic Review and Meta-Analysis.
by: Yong Ding, et al.
Published: (2016-01-01)

Early onset MSI-H colon cancer with <it>MLH1 </it>promoter methylation, is there a genetic predisposition?
by: Hes Frederik J, et al.
Published: (2010-05-01)

Vitamin and antioxidant rich diet increases <it>MLH1</it> promoter DNA methylation in DMT2 subjects
by: Switzeny Olivier J, et al.
Published: (2012-10-01)

Association Between hMLH1 Promoter Methylation and Risk of Gastric Cancer: A Meta-Analysis
by: Peng Ye, et al.
Published: (2018-04-01)

Colorectal tumour BRAF V600E and MLH1 promoter methylation status in the assessment of mismatch repair gene sequence variants of unknown clinical significance
by: Parsons M, et al.
Published: (2012-04-01)

Clinicopathological features of gliomatosis cerebri: a case report and review of literatures
by: Xingfu WANG, et al.
Published: (2011-04-01)

Clinicopathologic and genetic features of young patients with colorectal cancer
by: Aronson Melyssa, et al.
Published: (2010-05-01)

Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine Neoplasms
by: Mengjie Jiang, et al.
Published: (2017-01-01)

Clinicopathologic and Molecular Features of Colorectal Adenocarcinoma with Signet-Ring Cell Component.
by: Qing Wei, et al.
Published: (2016-01-01)

Relationships between p14ARF Gene Methylation and Clinicopathological Features of Colorectal Cancer: A Meta-Analysis.
by: Zhangjian Zhou, et al.
Published: (2016-01-01)

Downregulation of SPTAN1 is related to MLH1 deficiency and metastasis in colorectal cancer.
by: Anne Ackermann, et al.
Published: (2019-01-01)

MLH1 Gene Expression and Pathologic Factors in Iranian Patients with Colorectal Cancer
by: Ahdieh Hosseini Anvari, et al.
Published: (2020-11-01)

Specific variants in the MLH1 gene region may drive DNA methylation, loss of protein expression, and MSI-H colorectal cancer.
by: Miralem Mrkonjic, et al.
Published: (2010-10-01)

Promoter methylation of MLH1, PMS2, MSH2 and p16 is a phenomenon of advanced-stage HCCs.
by: Inga Hinrichsen, et al.
Published: (2014-01-01)

Clinicopathologic and endoscopic features of early-stage colorectal serrated adenocarcinoma
by: Daiki Hirano, et al.
Published: (2017-12-01)

Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features
by: Sandhya VENKATACHALA, et al.
Published: (2017-09-01)

Clinicopathological and molecular features of sporadic early onset colorectal cancers
by: Eusebi, Leonardo Henry Umberto <1979>
Published: (2016)

Clinicopathologic features of colorectal carcinoma: features predicting higher T-stage and nodal metastasis
by: Atif Ali Hashmi, et al.
Published: (2018-01-01)

MLH1 Deficiency Down-Regulates TLR4 Expression in Sporadic Colorectal Cancer
by: Melania Scarpa, et al.
Published: (2021-05-01)

Study of Promoter Methylation Patterns of HOXA2, HOXA5, and HOXA6 and Its Clinicopathological Characteristics in Colorectal Cancer
by: Daojiang Li, et al.
Published: (2019-05-01)